Settings8H · net · $10k
My profile
LegExchangePriceFund. /8hEach paymentNext inOIVol 24hLev
LONG7.7927+0.0502pay 0.0063% / 1h6m 17s$245K$3.4M25xLong Injective
SHORT8.2852−0.0112pay 0.0014% / 1h6m 17s$355K$3.7M25xShort Deribit
Price gap+6.320%117900s
Funding gap−0.0614% /8h

The gap pays +$633 on $10k if it goes back to its 7d average, but funding costs $18 a day and eats that in about 34 days. At the last 7 days' pace that is about 3 months.

If you open now and hold

on $10k a leg · figures of the last 7D, not a forecast
Funding−$45−0.0614% /8h now · paid −0.448% over the last 7D
Price—spread +6.320%117900s now · prices read too far apart to compare
Costsno datano order book for Injective
Result, before costs—no pointsneeds both prices read together

Price and funding

1h · history
ENTRY / EXIT · 7D
Entry now—
Entry average—
Best entry—
Exit now—
Exit average—
Best exit—
Exit free—
PRICE SPREAD · 7D
Now+6.320%
Average—
Range—
Wider than now—
FUNDING SPREAD · 7D
Average /8h—
Highest—
Lowest—
Paid you—

Where the spread has been, last 7D

share of time at each level

Funding on every exchange

/8h

INJ on 24 exchanges

lowest funding first

Before you open

1 ok · 3 to watch
  • Note: Order book unknown—
    No order-book sample for Injective: its slippage is not counted.
  • Note: Margin at max leverage$400 + $400
    Injective 25x, Deribit 25x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
  • OK: Same payment interval1h / 1h
    Both legs pay at the same time.
    Next 24h at the current rates, on $10k a leg: −$18.42Long Injective: 24 payments, −$15.06; short Deribit: 24 payments, −$3.36.
  • Watch: Prices read 33 h apart+6.320% vs −0.012%
    Part of this gap may be the market moving.
  • Watch: Long leg is thinner$245K vs $355K OI
    Injective sets your exit cost. Check its book before closing.
  • Note: No points program—
    Neither exchange runs points right now.
  • Watch: KYCInjective No · Deribit Yes
    ID, proof of address and a financial profile before any deposit; not for the US, Canada, Japan or retail UK clients.

Profit calculator

both legs, in and out
Position, each leg
Hold for
Orders
Price spread
Funding rate
Funding earned−0.0213%/8h × 21 periods−$44.81
Price spreadprices read too far apart to compare—
Slippage, 4 ordersno data for Injective—
Fee Injective bp × 2 orders−$0.02
Fee Deribit bp × 2 orders−$7.00
Net, fees only · 7 days · $10k−$51.83
price spread not counted: prices read too far apart
Costs to cover0.070%Break-evennever at this rate
Slippage: Injective: no order-book sample; Deribit: live order book, 5 min ago

Cost to enter

taker + slippage from mid, one side
BUY · LONGInjective—————
SELL · SHORTDeribit6.6710.2 bp−$1016.9 bp−$169doesn’t fitdoesn’t fit

Closing costs about the same again.
Injective: no data.

Alert

INJ news

posts that mention INJ, from every exchange
11-05 20:44InjectiveOtherThe Canary Staked INJ ETF, $INJC, is officially live and trading on @Nasdaq. Even the Nasdaq tower in Times Square says so. Out of thousands of crypto assets, only around a dozen have a US ETF. $INJ is now one of them. Wall Street, meet $INJ. @injective on X ↗
11-05 15:14InjectiveOther@Nasdaq @BitGo 7/ Eight years ago, we set out to make global financial markets accessible to everyone. Today, $INJ is on Nasdaq through a U.S. ETF, opening the door for billions to gain exposure to the asset powering a new global financial economy. And we're just getting started. @injective on X ↗
11-05 15:14InjectiveOther@Nasdaq 3/ Inside $INJC → Spot $INJ custodied by @BitGo → Aims to stake up to 90% of $INJ holdings → Net staking rewards restaked automatically In short, $INJ staking is now part of a U.S. regulated ETF. @injective on X ↗
11-05 15:14InjectiveOther@Nasdaq @BitGo 4/ $INJ now joins $BTC, $ETH and $SOL among the few major crypto assets with a dedicated U.S. ETF. A major step in bringing Injective to traditional capital markets. @injective on X ↗
11-05 15:14InjectiveToken@Nasdaq @BitGo 5/ Behind the $INJC ticker is the Layer 1 built for finance → 3B+ transactions → Over $1 Billion in tokenized assets → Over 7.2 Million in $INJ buybacks using onchain revenue → Infrastructure tailor-made for RWAs, perps, trading and privacy @injective on X ↗
11-05 15:14InjectiveOther@Nasdaq @BitGo 6/ Injective's institutional milestones go far beyond the $INJ ETF. → First L1 with an SEC registered transfer agent → Over $1 Billion tokenized onchain → Major tokenization project with global giant LG → Institutional Rail product release for banks and enterprises @injective on X ↗